Matches in Nanopublications for { ?s ?p "[Although TP53, NOTCH1, and SF3B1 mutations may impair prognosis of patients with chronic lymphocytic leukemia (CLL) receiving frontline therapy, the impact of these mutations or any other, alone or in combination, remains unclear at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Although TP53, NOTCH1, and SF3B1 mutations may impair prognosis of patients with chronic lymphocytic leukemia (CLL) receiving frontline therapy, the impact of these mutations or any other, alone or in combination, remains unclear at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_assertion description "[Although TP53, NOTCH1, and SF3B1 mutations may impair prognosis of patients with chronic lymphocytic leukemia (CLL) receiving frontline therapy, the impact of these mutations or any other, alone or in combination, remains unclear at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293375.RAYj125SimoOCNzz23JB8DN8a3_l3RE7NbMRoxBza9AeQ130_provenance.
- NP1293376.RApuBOP6cJN0-TCJSadJ9NBigFXUR8IuhO-7qPHbjM8qc130_assertion description "[Although TP53, NOTCH1, and SF3B1 mutations may impair prognosis of patients with chronic lymphocytic leukemia (CLL) receiving frontline therapy, the impact of these mutations or any other, alone or in combination, remains unclear at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293376.RApuBOP6cJN0-TCJSadJ9NBigFXUR8IuhO-7qPHbjM8qc130_provenance.